OMX Copenhagen PI
|
1 452,25
|
-31,81
|
-2,14%
|
Analysen zu OMX Copenhagen PI-Werten
| 12:30 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08:33 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 24.02.25 | Novo Nordisk Buy | UBS AG | |
| 20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Halten | DZ BANK | |
| 06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.25 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.